Doylestown Hospital

Az itteni vizsgálatok

Miről szól a helyszín 36 vizsgálata, a regiszteri adatlapjaik szerint.

Betegségek

• Tüdőrák8 vizsgálat
• Áttétes emlőrák5 vizsgálat
• Pitvarfibrilláció5 vizsgálat
• Vastagbélrák4 vizsgálat
• Hólyagrák3 vizsgálat
• Melanóma3 vizsgálat
• Tripla negatív emlőrák3 vizsgálat
• Elhízás2 vizsgálat
• Hasnyálmirigyrák2 vizsgálat
• Koszorúér-betegség2 vizsgálat
• Magas vérnyomás2 vizsgálat
• Máj- és epeúti rák2 vizsgálat
• és még 16

Fázis

• 3. fázis14 vizsgálat
• 2. fázis9 vizsgálat
• 2/3. fázis1 vizsgálat

Állapot

• Fut, nem toboroz19 vizsgálat
• Lezárult13 vizsgálat
• Még nem toboroz1 vizsgálat
• Toboroz1 vizsgálat
• Felfüggesztve1 vizsgálat
• Leállították1 vizsgálat

Fő szponzor

• National Cancer Institute (NCI)19 vizsgálat
• SWOG Cancer Research Network3 vizsgálat
• Abbott Medical Devices2 vizsgálat
• NRG Oncology2 vizsgálat
• Alliance for Clinical Trials in Oncology1 vizsgálat
• és még 9

Futó vizsgálatok

• Még nem toboroz

  Postpartum Care in the NICU Multi-Site

  NCT07873190· Children's Hospital of Philadelphia· Forrás

  Contact: Heather H Burris, MD, MPH

• Fut, nem toboroz

  Abbott Atrial Fibrillation Post Approval Study

  NCT05434650· Abbott Medical Devices· Forrás

• Fut, nem toboroz

  Firehawk Rapamycin Target Eluting Coronary Stent North American Trial

  NCT04562532· Shanghai MicroPort Medical (Group) Co., Ltd.· Forrás

• Fut, nem toboroz

  NCI COVID-19 in Cancer Patients, NCCAPS Study

  NCT04387656· National Cancer Institute (NCI)· Forrás

• Fut, nem toboroz

  Circulating Tumor DNA Testing in Predicting Treatment for Patients With Stage IIA Colon Cancer After Surgery

  NCT04068103· 2/3. fázis· NRG Oncology· Forrás

• Toboroz

  S1703 Serum Tumor Marker Directed Disease Monitoring in Patients With Hormone Receptor Positive Her2 Negative Metastatic Breast Cancer

  NCT03723928· SWOG Cancer Research Network· Forrás

  Contact: Ana Maria Lopez (principal investigator)

• Fut, nem toboroz

  Testing MK-3475 (Pembrolizumab) After Surgery for Localized Muscle-Invasive Bladder Cancer and Locally Advanced Urothelial Cancer

  NCT03244384· 3. fázis· National Cancer Institute (NCI)· Forrás

• Fut, nem toboroz

  Nivolumab and Ipilimumab in Treating Patients With Rare Tumors

  NCT02834013· 2. fázis· National Cancer Institute (NCI)· Forrás

• Fut, nem toboroz

  Testing MK-3475 (Pembrolizumab) as Adjuvant Therapy for Triple Receptor-Negative Breast Cancer

  NCT02954874· 3. fázis· National Cancer Institute (NCI)· Forrás

• Fut, nem toboroz

  Breast Cancer WEight Loss Study (BWEL Study)

  NCT02750826· 3. fázis· Alliance for Clinical Trials in Oncology· Forrás

• Fut, nem toboroz

  Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)

  NCT02465060· 2. fázis· National Cancer Institute (NCI)· Forrás

• Fut, nem toboroz

  Doxorubicin Hydrochloride and Cyclophosphamide Followed by Paclitaxel With or Without Carboplatin in Treating Patients With Triple-Negative Breast Cancer

  NCT02488967· 3. fázis· NRG Oncology· Forrás

• Fut, nem toboroz

  Tamoxifen Citrate or Z-Endoxifen Hydrochloride in Treating Patients With Locally Advanced or Metastatic, Estrogen Receptor-Positive, HER2-Negative Breast Cancer

  NCT02311933· 2. fázis· National Cancer Institute (NCI)· Forrás

• Fut, nem toboroz

  Crizotinib in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Removed by Surgery and ALK Fusion Mutations (An ALCHEMIST Treatment Trial)

  NCT02201992· 3. fázis· ECOG-ACRIN Cancer Research Group· Forrás

• Fut, nem toboroz

  Erlotinib Hydrochloride in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Completely Removed by Surgery (An ALCHEMIST Treatment Trial)

  NCT02193282· 3. fázis· National Cancer Institute (NCI)· Forrás

• Fut, nem toboroz

  Genetic Testing in Screening Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been or Will Be Removed by Surgery (The ALCHEMIST Screening Trial)

  NCT02194738· National Cancer Institute (NCI)· Forrás

• Fut, nem toboroz

  Exemestane With or Without Entinostat in Treating Patients With Recurrent Hormone Receptor-Positive Breast Cancer That is Locally Advanced or Metastatic

  NCT02115282· 3. fázis· National Cancer Institute (NCI)· Forrás

• Fut, nem toboroz

  Rituximab and Combination Chemotherapy With or Without Lenalidomide in Treating Patients With Newly Diagnosed Stage II-IV Diffuse Large B Cell Lymphoma

  NCT01856192· 2. fázis· National Cancer Institute (NCI)· Forrás

• Fut, nem toboroz

  Erlotinib Hydrochloride and Cabozantinib-s-Malate Alone or in Combination as Second or Third Line Therapy in Treating Patients With Stage IV Non-small Cell Lung Cancer

  NCT01708954· 2. fázis· National Cancer Institute (NCI)· Forrás

• Fut, nem toboroz

  Azacitidine With or Without Lenalidomide or Vorinostat in Treating Patients With Higher-Risk Myelodysplastic Syndromes or Chronic Myelomonocytic Leukemia

  NCT01522976· 2. fázis· National Cancer Institute (NCI)· Forrás

• Fut, nem toboroz

  Ipilimumab With or Without Sargramostim in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed by Surgery

  NCT01134614· 2. fázis· National Cancer Institute (NCI)· Forrás

Egyszerre toboroz

Hány vizsgálat toboroz itt egyszerre ugyanarra az indikációra. Darabszám, nem értékelés.

• Áttétes emlőrák1 toboroz
• Magas vérnyomás1 toboroz

Lezárt vizsgálatok

• Lezárult

  ADVENT Trial Long Term Outcomes Evaluating Atrial Fibrillation Progression Study

  NCT06526546· Boston Scientific Corporation· Forrás

• Leállították

  Posterior Wall Substrate Modification Using Irreversible Electroporation for Paroxysmal Atrial Fibrillation

  NCT06364215· Jorge Romero· Forrás

• Lezárult

  VOLT-AF IDE Clinical Study

  NCT06223789· Abbott Medical Devices· Forrás

• Lezárult

  Treatment of Persistent Atrial Fibrillation With Sphere-9 Catheter and Affera Mapping and Ablation System

  NCT05120193· Medtronic Cardiac Ablation Solutions· Forrás

• Lezárult

  A Study of Tirzepatide (LY3298176) in Participants With Heart Failure With Preserved Ejection Fraction (HFpEF) and Obesity: The SUMMIT Trial

  NCT04847557· 3. fázis· Eli Lilly and Company· Forrás

• Lezárult

  PIONEER III Trial to Assess Safety and Efficacy of the BuMA Supreme™ Drug Coated Coronary Stent in Patients With Coronary Disease

  NCT03168776· Sino Medical Sciences Technology Inc.· Forrás

• Lezárult

  Cisplatin With or Without Veliparib in Treating Patients With Recurrent or Metastatic Triple-Negative and/or BRCA Mutation-Associated Breast Cancer With or Without Brain Metastases

  NCT02595905· 2. fázis· National Cancer Institute (NCI)· Forrás

• Lezárult

  Carotid Revascularization and Medical Management for Asymptomatic Carotid Stenosis Trial

  NCT02089217· Mayo Clinic· Forrás

• Lezárult

  Ipilimumab With or Without Bevacizumab in Treating Patients With Stage III-IV Melanoma That Cannot Be Removed by Surgery

  NCT01950390· 2. fázis· National Cancer Institute (NCI)· Forrás

• Lezárult

  S1216, Phase III ADT+TAK-700 vs. ADT+Bicalutamide for Metastatic Prostate Cancer

  NCT01809691· 3. fázis· SWOG Cancer Research Network· Forrás

• Lezárult

  S0931, Everolimus in Treating Patients With Kidney Cancer Who Have Undergone Surgery

  NCT01120249· 3. fázis· SWOG Cancer Research Network· Forrás

• Lezárult

  Tamoxifen Citrate or Letrozole With or Without Bevacizumab in Treating Women With Stage IIIB or Stage IV Breast Cancer

  NCT00601900· 3. fázis· National Cancer Institute (NCI)· Forrás

• Lezárult

  Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-small Cell Lung Cancer That Was Removed By Surgery

  NCT00324805· 3. fázis· National Cancer Institute (NCI)· Forrás

• Lezárult

  Oxaliplatin, Leucovorin, and Fluorouracil With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II Colon Cancer

  NCT00217737· 3. fázis· National Cancer Institute (NCI)· Forrás